Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A telerehabilitation program improves postural control in multiple sclerosis patients: a spanish preliminary study.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
Multiple sclerosis: relapses, resource use, and costs.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
Epigenetic mechanisms in neurological and neurodegenerative diseases.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Multiple sclerosis, natalizumab, and PML: helping patients decide.
Targeting thalamic tremor cells in deep brain stimulation for multiple sclerosis-induced complex tremor.
Associations of Systemic Diseases with Intermediate Uveitis.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Diffuse astrocytoma arising within a demyelinating plaque.
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Ventricular arrhythmia in a male MS patient on fingolimod.
Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers.
Pages
« first
‹ previous
…
573
574
575
576
577
578
579
580
581
…
next ›
last »